These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5801808)

  • 1. Purification and stability of specifically tritium labelled lysine vasopressin (tyrosine2-3-T-lysine8-sopressin).
    Carlsson L; Pliska V; Thorn NA
    Experientia; 1969; 25(7):749. PubMed ID: 5801808
    [No Abstract]   [Full Text] [Related]  

  • 2. Tritium labelling of 8-lysine vasopressin and its purification by affinity chromatography on sepharose bound neurophysins.
    Pradelles P; Morgat JL; Fromageot P; Camier M; Bonne D; Cohen P; Bockaert J; Jard S
    FEBS Lett; 1972 Oct; 26(1):189-92. PubMed ID: 4636728
    [No Abstract]   [Full Text] [Related]  

  • 3. Some metabolites of specifically tritium labelled lysine-vasopressin: identification by thin-layer chromatography and determination by the liquid scintillation technique.
    Pliska V; Barth T; Thorn NA
    Acta Endocrinol (Copenh); 1971 May; 67(1):1-11. PubMed ID: 4930026
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoassay for lysine 8 -vasopressin (LVP): comparison of biological and immunological activity of lysine-vasopressin and some of its synthetic analogues.
    Marchetti J
    Experientia; 1973 Mar; 29(3):351-3. PubMed ID: 4122649
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis of tritium-labelled oxytocin and lysine-vasopressin.
    Carlsson L; Sjöholm I
    Acta Chem Scand; 1966; 20(1):259-60. PubMed ID: 5933526
    [No Abstract]   [Full Text] [Related]  

  • 6. Long term stability of lysine vasopressin and of specifically tritiated lysine vasopressin in weakly acidic aqueous solutions.
    Pliska V; Meyer-Grass M; Bersinger N; Carlsson L; Melin P; Vilhardt H
    Experientia; 1980 Oct; 36(10):1145-6. PubMed ID: 7418787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of radioimmunoassay to bioassay: in vitro studies with synthetic lysine vasopressin in aqueous solution inactivated by heat.
    Lembøl HL
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):465-73. PubMed ID: 581018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of the behavioural and endocrine effects of lysine vasopressin by tryptic digestion.
    de Wied D; Greven HM; Lande S; Witter A
    Br J Pharmacol; 1972 May; 45(1):118-22. PubMed ID: 4537756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of vasopressin in adenohypophysis: research into its role in corticotrope activity.
    Chateau M; Marchetti J; Burlet A; Boulange M
    Neuroendocrinology; 1979; 28(1):25-35. PubMed ID: 431770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on isolated secretory granules from bovine neurohypophyses. Distribution of labelled granules on a density gradient. Release of tritiated lysine-vasopressin and endogenous arginine-vasopressin during stimulation procedures.
    Vilhardt H; Tondevold E
    Acta Endocrinol (Copenh); 1972 Aug; 70(4):625-35. PubMed ID: 5068395
    [No Abstract]   [Full Text] [Related]  

  • 11. Thiol-disulfide interchange reactions between serum albumin and disulfides.
    Edwards FB; Rombauer RB; Campbell BJ
    Biochim Biophys Acta; 1969 Nov; 194(1):234-45. PubMed ID: 5353128
    [No Abstract]   [Full Text] [Related]  

  • 12. Intra-axonal transport and turnover of neurohypophysial hormones in the rat.
    Jones CW; Pickering BT
    J Physiol; 1972 Dec; 227(2):553-64. PubMed ID: 4678722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of lysine vasopressin with free and agarose-bound bovine neurophysin II. Two classes of binding sites.
    Pliska V; Sachs H
    Eur J Biochem; 1974 Jan; 41(2):229-39. PubMed ID: 4856266
    [No Abstract]   [Full Text] [Related]  

  • 14. Precursors in the biosynthesis of vasopressin and oxytocin in the rat. Characteristics of all the components in high-performance liquid chromatography.
    Swann RW; Gonzalez CB; Birkett SD; Pickering BT
    Biochem J; 1982 Nov; 208(2):339-49. PubMed ID: 7159402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of the half-life of antidiuretic hormone (lysine-vasopressin) in man by a radioimmunologic method].
    Burguburu AM; Geelen G
    C R Seances Soc Biol Fil; 1974; 168(8-9):965-70. PubMed ID: 4282342
    [No Abstract]   [Full Text] [Related]  

  • 16. Degradation of oxytocin, lysine-vasopressin, angiotensin II and angiotensin-II-amide by oxytocinase (cystine aminopeptidase).
    Sjöholm I; Yman L
    Acta Pharm Suec; 1967 Apr; 4(2):65-76. PubMed ID: 4292447
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific uptake of radioactivity from 3 H-oxytocin by surviving segments of rat mammary gland.
    Soloff MS; Swartz TL; Saffran M
    Endocrinology; 1972 Jul; 91(1):213-6. PubMed ID: 5063545
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiation inactivation of purified lysine vasopressin.
    Odell WD; Swain RW; Bowers CY; Schally AV
    Experientia; 1966 May; 22(5):342-4. PubMed ID: 5957235
    [No Abstract]   [Full Text] [Related]  

  • 19. Photoaffinity labelling of the renal V2 vasopressin receptor. Identification and enrichment of a vasopressin-binding subunit.
    Fahrenholz F; Boer R; Crause P; Tóth MV
    Eur J Biochem; 1985 Nov; 152(3):589-95. PubMed ID: 2996895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological properties of synthetic Ser 4 -Arg 8 -oxytocin (Ile 3 -Ser 4 -arginine vasopressin): role of the residue No. 4 in the hormone-pressor receptor interaction.
    Chauvet J; Chauvet MT; Acher R
    Experientia; 1972 Dec; 28(12):1493-5. PubMed ID: 4347407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.